356 related articles for article (PubMed ID: 16331758)
1. The relationship between social deprivation, disease outcome measures, and response to treatment in patients with stable, long-standing rheumatoid arthritis.
Harrison MJ; Tricker KJ; Davies L; Hassell A; Dawes P; Scott DL; Knight S; Davis M; Mulherin D; Symmons DP
J Rheumatol; 2005 Dec; 32(12):2330-6. PubMed ID: 16331758
[TBL] [Abstract][Full Text] [Related]
2. The overall status in rheumatoid arthritis (OSRA) measure--further evidence to support its use in clinical practice.
Harrison MJ; Hassell A; Dawes PT; Scott DL; Knight SM; Davis MJ; Mulherin D; Symmons DP
Rheumatology (Oxford); 2007 May; 46(5):849-55. PubMed ID: 17264089
[TBL] [Abstract][Full Text] [Related]
3. Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial. Leflunomide Rheumatoid Arthritis Investigators Group.
Tugwell P; Wells G; Strand V; Maetzel A; Bombardier C; Crawford B; Dorrier C; Thompson A
Arthritis Rheum; 2000 Mar; 43(3):506-14. PubMed ID: 10728742
[TBL] [Abstract][Full Text] [Related]
4. Generic quality-of-life assessment in rheumatoid arthritis.
Tugwell P; Idzerda L; Wells GA
Am J Manag Care; 2007 Dec; 13 Suppl 9():S224-36. PubMed ID: 18095786
[TBL] [Abstract][Full Text] [Related]
5. Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration.
Anderson JJ; Wells G; Verhoeven AC; Felson DT
Arthritis Rheum; 2000 Jan; 43(1):22-9. PubMed ID: 10643696
[TBL] [Abstract][Full Text] [Related]
6. High dose chemotherapy and hematopoietic stem cell transplantation: a study of treatment preference in patients with rheumatoid arthritis and rheumatologists.
Verburg RJ; Mahabali SD; Stiggelbout AM; Sont JK; van Laar JM
J Rheumatol; 2002 Aug; 29(8):1653-8. PubMed ID: 12180724
[TBL] [Abstract][Full Text] [Related]
7. Patients with moderate rheumatoid arthritis (RA) achieve better disease activity states with etanercept treatment than patients with severe RA.
Keystone E; Freundlich B; Schiff M; Li J; Hooper M
J Rheumatol; 2009 Mar; 36(3):522-31. PubMed ID: 19228659
[TBL] [Abstract][Full Text] [Related]
8. Patients with stable long-standing rheumatoid arthritis continue to deteriorate despite intensified treatment with traditional disease modifying anti-rheumatic drugs--results of the British Rheumatoid Outcome Study Group randomized controlled clinical trial.
Symmons D; Tricker K; Harrison M; Roberts C; Davis M; Dawes P; Hassell A; Knight S; Mulherin D; Scott DL;
Rheumatology (Oxford); 2006 May; 45(5):558-65. PubMed ID: 16263778
[TBL] [Abstract][Full Text] [Related]
9. Patient-reported outcomes in a randomized trial comparing four different treatment strategies in recent-onset rheumatoid arthritis.
van der Kooij SM; de Vries-Bouwstra JK; Goekoop-Ruiterman YP; Ewals JA; Han KH; Hazes JM; Kerstens PJ; Peeters AJ; van Zeben D; Breedveld FC; Huizinga TW; Dijkmans BA; Allaart CF
Arthritis Rheum; 2009 Jan; 61(1):4-12. PubMed ID: 19116965
[TBL] [Abstract][Full Text] [Related]
10. Comparison of rheumatoid arthritis clinical trial outcome measures: a simulation study.
Anderson JJ; Bolognese JA; Felson DT
Arthritis Rheum; 2003 Nov; 48(11):3031-8. PubMed ID: 14613263
[TBL] [Abstract][Full Text] [Related]
11. Efficient management of rheumatoid arthritis significantly reduces long-term functional disability.
Tanaka E; Mannalithara A; Inoue E; Hara M; Tomatsu T; Kamatani N; Singh G; Yamanaka H
Ann Rheum Dis; 2008 Aug; 67(8):1153-8. PubMed ID: 17971459
[TBL] [Abstract][Full Text] [Related]
12. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
Hyrich KL; Watson KD; Silman AJ; Symmons DP;
Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
[TBL] [Abstract][Full Text] [Related]
13. Improved health-related quality of life for patients with active rheumatoid arthritis receiving rituximab: Results of the Dose-Ranging Assessment: International Clinical Evaluation of Rituximab in Rheumatoid Arthritis (DANCER) Trial.
Mease PJ; Revicki DA; Szechinski J; Greenwald M; Kivitz A; Barile-Fabris L; Kalsi J; Eames J; Leirisalo-Repo M
J Rheumatol; 2008 Jan; 35(1):20-30. PubMed ID: 18050385
[TBL] [Abstract][Full Text] [Related]
14. Responsiveness of health status measures and utility-based methods in patients with rheumatoid arthritis.
Salaffi F; Stancati A; Carotti M
Clin Rheumatol; 2002 Nov; 21(6):478-87. PubMed ID: 12447631
[TBL] [Abstract][Full Text] [Related]
15. Association of concomitant fibromyalgia with worse disease activity score in 28 joints, health assessment questionnaire, and short form 36 scores in patients with rheumatoid arthritis.
Ranzolin A; Brenol JC; Bredemeier M; Guarienti J; Rizzatti M; Feldman D; Xavier RM
Arthritis Rheum; 2009 Jun; 61(6):794-800. PubMed ID: 19479706
[TBL] [Abstract][Full Text] [Related]
16. Does clinical remission lead to normalization of EQ-5D in patients with rheumatoid arthritis and is selection of remission criteria important?
Linde L; Sørensen J; Østergaard M; Hørslev-Petersen K; Hetland ML
J Rheumatol; 2010 Feb; 37(2):285-90. PubMed ID: 20080905
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial.
Ogrendik M
Clin Ther; 2009 Aug; 31(8):1754-64. PubMed ID: 19808134
[TBL] [Abstract][Full Text] [Related]
18. Relationship between pack-year history of smoking and response to tumor necrosis factor antagonists in patients with rheumatoid arthritis.
Mattey DL; Brownfield A; Dawes PT
J Rheumatol; 2009 Jun; 36(6):1180-7. PubMed ID: 19447930
[TBL] [Abstract][Full Text] [Related]
19. Short-term outcome after anti-tumor necrosis factor-alpha therapy in rheumatoid arthritis: do we need to revise our assessment criteria?
El Miedany Y; Youssef SS; El Gaafary M
J Rheumatol; 2006 Mar; 33(3):490-7. PubMed ID: 16511918
[TBL] [Abstract][Full Text] [Related]
20. Validity of area-under-the-curve analysis to summarize effect in rheumatoid arthritis clinical trials.
Pham B; Cranney A; Boers M; Verhoeven AC; Wells G; Tugwell P
J Rheumatol; 1999 Mar; 26(3):712-6. PubMed ID: 10090188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
